Skip to main content
Clinical Trials/NL-OMON22673
NL-OMON22673
Completed
Not Applicable

Investigating new imaging criteria for non-operative treatment following neoadjuvant chemoradiation in rectal cancer patients

eiden Unversity Medical Center0 sites20 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
eiden Unversity Medical Center
Enrollment
20

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Biopsy proven adenocarcinoma of the rectum
  • Patients with locally advanced rectal cancer who, according to current guidelines, are eligible for treatment with neoadjuvant chemoradiation
  • Patients treated in the LUMC, HMC, Alrijne Leiderdorp or Groene Hart Ziekenhuis Gouda.
  • Age 18 years and older;
  • Willing to participate in all aspects of the study

Exclusion Criteria

  • Patients with rectal cancer, receiving chemoradiation as part of the TESAR trial
  • Diabetes mellitus
  • Claustrofobia (low dose benzodiazepines are allowed)
  • Prior radiotherapy to the pelvis
  • If female and fertile: signs and symptoms of pregnancy or a positive pregnancy test / breast\-feeding (a formal negative pregnancy test is not obligatory
  • Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule
  • Contraindications for Magnetic Resonance Imaging
  • Patient has evidence of infection in the 14 days prior to the FDG\-PET/CT scan localised to the lower abdomen, pelvic region, lower back, inguinal region
  • Inability to tolerate lying supine for the duration of an FDG\-PET/CT examination (\~30min)

Investigators

Sponsor
eiden Unversity Medical Center

Similar Trials